References
- 1. Futrakul N, Yenrudi S, Sensirivatana R, Watana D, Laohapaibul A, Watanapenphaibul K, et al. Peritubular capillary flow determines tubulointerstitial fibrosis in idiopathic nephritic syndrome. Ren Fail. 2000; 22: 329-35.
- 2. Kang DH, Kanellis J, Hugo C, Truong L, Anderson S, Kerjaschki D, et al. Role of the microvascular endothelium in progressive renal disease. J Am Soc Nephrol. 2002; 13:806-16.10.1097/01.ASN.0000034910.58454.FD
- 3. Futrakul N, Sila-asna M, Futrakul P. Therapeutic strategy towards renal restoration in chronic kidney disease. Asian Biomed. 2007; 1:33-44.
- 4. Coresh J, Astor BC, Green T, Ehnogan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: third national health and nutrition examination survey. Am J Kidney Dis. 2003; 41:1-13.10.1053/ajkd.2003.50007
- 5. Obrader GT, Pereira BJ, Kausz AT. Chronic kidney disease in the United States: an underrecognized problem. Semin Nephrol. 2002; 22:441-8.10.1053/snep.2002.2002.35962
- 6. Ruggenenti P, Schicppati A, Remuzzi G. Progression, remission, regression of chronic kidney diseases. Lancet 2001; 357:1601-8.
- 7. Futrakul N, Butthep P, Futrakul P. Altered vascular homeostasis in chronic kidney disease. Clin Hemoeheol Microcirc. 2008; 38:201-7.
- 8. Futrakul N, Butthep P, Futrakul P. Altered vascular homeostasis in type 2 diabetic nephropathy. Ren Fail. 2009; 31:207-10.
- 9. Woolf AS, Gnudi L, Long DA. Roles of angiopoietins in kidney development and disease. J Am Soc Nephrol. 2009; 20:239-44.10.1681/ASN.2008020243
- 10. Cooper ME, Vranes D, Youssef S, Stacker SA, Cox AJ, Rizkalla B, et al. Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR2 in experimental diabetes. Diabetes. 1999; 48: 2229-39.10.2337/diabetes.48.11.2229
- 11. Nakagawa T, Kosugi T, Hanada M, Rivard CJ, Long DA. Abnormal angiogenesis in diabetic nephropathy. Diabetes. 2009; 58:1471-8.10.2337/db09-0119
- 12. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagna PJ, Jacobowitz GR, et al. Human endothelial progenitor cells from type 2 diabetics exhibit impaired, proliferation, adhesion, and incorporation into vascular structures. Circulation. 2002; 106:2781-6.10.1161/01.CIR.0000039526.42991.93
- 13. Satcholl SC, Anderson KL, Mathieson PW. Angiopoietin 1 and vascular endothelial growth factor modulate human glomerular endothelial cell barrier properties. J Am Soc Nephrol. 2004; 15:566-74.10.1097/01.ASN.0000115397.22519.03
- 14. Yao D, Taquachi T, Matsumura T, Parstell R, Edelstein D, Giardino I, et al. High glucose increases angiopoietin 2 transcription in microvascular endothelial cells through methylglyoxal modification of in Sin 3A. J Biol Chem. 2007; 282; 31038-45.10.1074/jbc.M704703200
- 15. Futrakul N, Futrakul P. A mildly altered vascular homeostasis in early stage of CKD. Ren Fail. 2009; 31: 538-43.
- 16. Futrakul P, Yenrusi S, Futrakul N, Sensirivatana R, Kingwatanakul P, Jungthirapanich J, et al. Tubular functional tubulointerstitial disease. Am J Kidney Dis. 1999; 33:886-91.10.1016/S0272-6386(99)70421-X
- 17. Futrakul N, Futrakul P, Siriviriyakul P. Correction of peritubular capillary flow reduction with vasodilators restores function in focal segmental glomerulosclerotic nephrosis. Clin Hemorrheo Microcirc. 2004; 31:197-205.
- 18. Futrakul N, Futrakul P. Improved vascular repair is relevant to enhanced renal function with vasodilators in early stage of chronic kidney disease. Asian Biomed. 2010; 4:153-7.